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Small ubiquitin-related modifiers (SUMOs) belong to the ubiquitin-like (Ubl) protein family; they are structurally similar to ubiquitin and have the ability to conjugate with target proteins. Vertebrates encode three SUMO isoforms: SUMO-1, SUMO-2, and SUMO-3. Mature SUMO-2 exhibits approximately 97% sequence identity to mature SUMO-3 (together designated further as SUMO-2/3). All three SUMO isoforms are conjugated to target proteins by common enzymatic components of the SUMO conjugation pathway (1, 2) ; the reversible nature of SUMO attachment provided by SUMO proteases (reviewed in 3) makes SUMOs f lexible posttranslational modifiers. SUMOylation, conjugation of SUMO to target proteins, plays role in many cellular processes such as subcellular localization, transcription regulation, DNA replication, and repair (2, 4) .
Conjugation of SUMO-2/3 to cellular targets increases under various stress stimuli (5, 6) or under proteasomal inhibition (7) . Even though the proteome of SUMO-2/3 targets was identified in heat-shocked cells (8) and in cells with inhibited proteasomal activity (9, 10) , the precise role of stress-induced SUMOylation still is not well understood. However, an association between ubiquitin-targeted degradation and a protective role under stress conditions has been proposed (7) (8) (9) . In the brain, SUMO-2/3 conjugation was shown to be strongly activated in hibernating animals during the torpor phase (11, 12) , and it was suggested that this served as a protective response by shielding neurons from damage induced by low blood flow and substrate deprivation (12) . Further, SUMO-2/3 conjugation is activated during deep hypothermia (13) and a significant increase in the level of SUMO2/3-conjugated proteins was found in the brains of animals subjected to transient global or focal cerebral ischemia (14) . Since SUMO-2/3 knockdown was shown to increase vulnerability of neuronal cells to oxygen and glucose deprivation (OGD), the activation of SUMO-2/3 conjugation was suggested to serve as an endogenous neuroprotective stress response (15) . In this context, it was reported that enhanced SUMOylation during OGD in cultured hippocampal neurons is not attributable to increased SUMO gene expression (16) . In addition to these findings, it was proposed that SUMO-2/3 conjugation was connected to protein quality control at a cellular level in various physiological and pathological processes (10, 17) . In the near future, we expect to see more studies focusing on the detail of SUMOylation in tissues under different pathological conditions and, eventually, treatment of disease by activation or inhibition of SUMOylation as proposed (15) .
The most frequently used technique for detecting changes in SUMO-2/3 conjugation is Western blot analysis, consisting of fractionation of cell lysates by SDS-PAGE followed by electroblotting of separated proteins from the polyacrylamide gel to a nitrocellulose membrane and detection of SUMO-2/3 with a specific antibody. The qualitative marker of covalent SUMO-2/3 conjugation to protein targets is a decrease of SUMO-2/3 electrophoretic mobility, often corresponding to a molecular weight ranging from 60 to 200 kDa. However, since large sets of proteins may be modified by SUMO-2/3 (18, 19) , a smear is often observed in Western blot analysis (5,10; Figure 1 ). The signal intensity of the smear corresponding to conjugated SUMO-2/3 is dramatically increased compared with the original signal from unconjugated SUMO-2/3. Although the higher signal intensity of conjugated SUMO-2/3 has been observed many times (5, 10) , the nature of this phenomenon has not been discussed. One possible explanation is that immunoreactive epitopes in SUMO-2/3 become easier for antibodies to recognize following conjugation because of immobilization of SUMO-2/3 with its protein targets on the membrane. Other possibilities are that SUMO-2/3 conjugates transfer more readily from the polyacrylamide gel than free SUMO-2/3 or that free SUMO-2/3 has extremely low-binding affinity for the membrane. Here we used heat shock and treatment with proteasomal inhibitor MG132 as model conditions to induce accumulation of SUMO-2/3 conjugates in HEK 293T cells and analyzed SUMOylation by Western blot analysis on nitrocellulose (0.45 µm) or PVDF (0.2 µm) membranes ( Figure 1 , lanes 2 and 3); PVDF membranes proved to be more suitable for simultaneous detection of free SUMO-2/3 and its conjugates under the same exposure time. Parallel analysis of lysates where SUMO-2/3 was deconjugated by the SUMO-specific isopeptidase Ulp1 showed that the increased signal intensity of SUMO-2/3 is caused exclusively by SUMO-2/3 conjugation and not by increased expression because similar signal levels from deconjugated SUMO-2/3 were detected under all tested conditions ( Figure 1 , compare lanes [4] [5] [6] . Surprisingly, similar qualitative findings for SUMO-2/3 conjugate intensities were observed when lysates were directly dot-blotted onto nitrocellulose or PVDF membranes and probed with antibodies against SUMO-2/3 ( Figure 1 ). The signal change caused by conjugation did not depend on membrane or antibody type because N-teminally HA fused SUMO-3 protein expressed in HEK 293T cells showed identical behavior using mouse monoclonal anti-HA antibody (data not shown). The samples used for Western blot analysis contained intentionally high total protein concentrations to obtain a visible decrease of free SUMO-2/3 levels as an indicator of increased conjugation. Although unconjugated SUMO-2/3 was detectable by Western blot, almost no signal was observed by dot blot analysis either on nitrocellulose or PVDF membranes ( Figure 1, lanes 4-6) . This observation was surprising considering that in addition to free SUMO-2/3, there were three additional cross reactive bands detected with Western blot (Figure 1 , lanes 4-6; 20) . Independent of the type of membrane, these results indicate that the SUMO-2/3 signal on the dot blot is a function of the level of SUMO-2/3 conjugates. Free SUMO-2/3 is far less detectable by dot blot than by Western blot, possibly because of lower affinity to the membrane, competition with other cellular proteins for membrane binding sites, or shielding of epitopes by other cellular proteins or the membrane. Dot blot previously has been used to detect global cellular levels of SUMO-1 (21) . However, because of the increase of SUMO-2/3 signal intensity upon its conjugation, it is not possible to use this method to assess global cellular levels of SUMO-2/3 as it was used for SUMO-1 (21) .
Next, we examined the dependence of the Western blot and dot blot signal intensity on the percentage of conjugated SUMO-2/3 ( Figure 2) . To obtain defined levels of conjugated SUMO-2/3 in total cell lysates, the lysate from heatshocked cells was mixed at various ratios with cell lysate of the same origin but treated with Ulp1 for global SUMO-2/3 deconjugation. The signal intensity of free SUMO-2/3 and SUMO-2/3 conjugates in the individual samples with comparable total protein content was verified by Western blot analysis (Figure 2A ). The decrease of free SUMO-2/3 signal correlated with the theoretical increase of the level of SUMO-2/3 conjugates. However, Figure 1 . Immunodetection of SUMO-2/3 conjugates on nitrocellulose and PVDF membranes. HEK 293T cells were cultivated in Dulbecco's modified Eagle's medium (DMEM, Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum and vitamins (both from Invitrogen, Life Technologies, Grand Island, NY, USA) on a 35 mm Petri dish to 80% confluence. Heat shock was performed by cultivation of cells at 42°C for 1 h (lines 3 and 6). Proteasomes were inhibited using 10 µM MG132 (PeptaNova, Sandhausen, Germany) for 2 h at 37°C (line 2 and 5). Both treated and control cells were released from the cultivation surface by 1 mL of cultivation media and two 400 µl cell suspension aliquots were collected. Cells were pelleted at 1,000× g for 1 min, medium was discarded, and cell pellets were lysed as follows: to samples shown in Lanes 1, 2, and 3, 100 µl of reducing SDS-PAGE Laemli sample buffer (100 mM Tris, pH 6.8, 8% SDS, 24% glycerol, 0.02% Coomassie blue G-250, 200 mM dithiothreitol) were added, lysate was sonicated and boiled for 10 min; in lanes 4, 5 and 6 (deconjugation of SUMO-2/3), the cell pellet was resuspended in 50 µl of native lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 0,4% NP40, 1 mM DTT, 1 mM EDTA, 20 µM MG132, 20 µg/mL Leupeptin, 1mM PMSF, pH 8) containing 1 U of S. cerevisiae protease Ulp1 (Invitrogen). The SUMO-2/3 deconjugation reaction took place for 2 h at room temperature and then 50 µl of reducing SDS-PAGE Laemli sample buffer was added; then the lysate was sonicated and boiled for 10 min. For Western blot, samples (10 µl) were analyzed by SDS-PAGE and transferred to nitrocellulose or PVDF membranes in transfer buffer for 1h at 100V. For dot blot, samples (10 µl) were diluted in TBS (20 mM Tris.HCl, 150 mM NaCl, pH 8.0) to a final volume of 200 µl and spotted onto a nitrocellulose or PVDF membrane using a BioDot SF Microfiltration Apparatus (Bio-Rad, Hercules, CA, USA) according to the manufacturer's instructions. After Western and dot blotting, the membranes were incubated in blocking solution (5% fat-free milk, 0.1% Tween-20 in PBS) for 1 h. Endogenous SUMO-2/3 was detected using polyclonal anti-SUMO-2 antibody (Invitrogen) at a 1:750 dilution. Protein level normalization was carried out by rabbit polyclonal anti-GAPDH antibody (Sigma-Aldrich), used 1:10,000 dilution. Secondary anti-rabbit IgG specific HRP-conjugated antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used at 1:5000 dilution. SUMOylated proteins were visualized by SuperSignal West Femto chemiluminescent substrate (Pierce, Thermo Scientific, Rockford, IL, USA) according to the manufacturer's instructions.
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Molecular Biology Clinical Diagnostics/ Assay Development for the increase of SUMO-2/3 conjugate, the signal was visible in the interval of 0% (only unconjugated SUMO-2/3) to approximately 60% (SUMO-2/3 conjugated on nitrocellulose), and up to 90% on PVDF (Figure 2 ). Dot blot analysis showed an approximately linear correleation between the signal and the level of conjugated SUMO-2/3 in the interval from 0% to 60% of SUMO-2/3 conjugated on nitrocellulose and 0 to 90% conjugated on PVDF, which was in agreement with results obtained by Western blot (Figure 2 ). Even with reduced protein quantities near the detection limit of dot blot, we observed a constant signal above 60%-70% of SUMO-2/3 conjugated on nitrocellulose membrane. Based on these results, we recommend using PVDF membranes for evaluation of global changes in SUMO-2/3 conjugation by dot blot. Finally, we used dot blot to screen for changes in global SUMO-2/3 conjugation in HEK 293T cells grown under different conditions (Figure 3 ). Each sample was tested in four replicates using dot blot and the signal intensities were evaluated using Total Lab TL100 software and statistically processed (Figure 3) . The results obtained from these dot blot analyses on PVDF membranes reflect the fact that treatment by MG132-induced SUMO-2/3 conjugate accumulation in a time dependent manner (Figure 3, MG132-1h and 2h ), while treatment with the translational inhibitor cycloheximide strongly decreased the MG132-induced SUMO-2/3 conjugation. This negative effect of cycloheximide on MG132-induced conjugation of SUMO-2/3 in our assay agrees with previous observations (10, 17) , where SUMO-2/3 deconjugation assays showed that cycloheximide treatment did not influence global cellular SUMO-2/3 levels, but instead affected SUMO-2/3 conjugation by blocking production of novel SUMOylation targets (17) .
As shown above, our approach to evaluate global changes in cellular SUMO-2/3 conjugation is based on increased signal intensity of SUMO-2/3 upon its conjugation. We used this phenomenon to screen for changes in cellular SUMO-2/3 conjugation under different conditions by dot blot analysis on nitrocellulose and PVDF membrane, and showed that the PVDF membrane was more suitable for this appli- were cultivated at 42°C for 1 h. Cells were released by 2 mL of cultivation medium, divided into two equal parts, and centrifuged (1,000× g, 1 min). For SUMO-2/3 conjugate detection, the cell pellet was lysed in 300 µl of Laemli sample buffer. A second pellet was resuspended in 150 µl of native lysis buffer for SUMO-2/3 deconujugation (as described in the Figure  1 legend), incubated for 2 h at room temperature, and then 150 µl of Laemli sample buffer was added. The lysates were sonicated and boiled for 10 min. The total cell lysates with conjugated (100% conjugation) and deconjugated (0% conjugation) SUMO-2/3 were mixed to generate a series of samples including amounts of conjugated SUMO-2/3 from 0 to 100%. Samples were analyzed by Western blot (A) or dot blot (B) either on nitrocellulose or PVDF membrane with immunochemical detection. The quantification of dot blots was carried out using TotalLab TL100 software (Nonlinear Dynamics USA, Durham, NC, USA).
A B Figure 3 . Quantification of changes in global SUMO-2/3 conjugation by dot blot analysis on PVDF membrane. Dot blots were performed on PVDF membranes as described in the Figure 1 legend. HEK 293T cells were cultivated on 12 well culture plates: control at 37°C (control), translation inhibition by 30 µg/mL cycloheximide for 2h (CHX-2h), proteasomal inhibition by 20 µM MG132 for 1 or 2 h (MG132-1h or MG132-2h), and combined translational and proteasomal inhibition (MG132/CHX-2h). For cells subjected to both translational and proteasomal inhibition, the cells were first subjected to inhibition of translation for 20 min and then exposed to proteasomal inhibitor MG132 for 1 or 2 h in the presence of the translational inhibitor. Each sample was tested in four replicates and the signal intensity was analyzed statistically and by Total Lab TL100 software.
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